Skip to main content
. 1997 Oct 6;186(7):1107–1117. doi: 10.1084/jem.186.7.1107

Table 4.

Inhibition of Activation of CPP32-like Protease and Apoptosis by Cell-permeable CPP32 Inhibitors

Cell treatment* Apoptotic cells DEVD-pNa cleaving activity DNA fragmentation
% nmol/h/mg %
0  9.5 0
TNF 2.0 ng/ml 41 78.8 48 ± 4.8
TNF + cpDEVD-CHO 1.0 μM 8  1.1 0
TNF + cpDEVD-CHO 0.5 μM 11 38.6 21 ± 0.8
TNF + cpDEVD-CHO 0.25 μM 20 46.5 ND
TNF + cpDEVD-CHO 0.125 μM 31 80.5 ND
0     0 0
UV light 0.06 J/cm2 58 20.4 53 ± 4.2
UV light + cpDEVD-CHO 1.0 μM 11  3.4 12 ± 0.6
UV light + cpDEVD-CHO 0.25 μM 38  8.8 ND
0  3.5 0
UV light 0.06 J/cm2 59 80.4 46 ± 4.6
UV light + DEVD(meth)-cmk 10 μM 8 12.2 0
UV light + DEVD(meth)-cmk 5 μM 18 27.8 0
UV light + DEVD(meth)-cmk 2.5 μM 39 46.6 15 ± 4.5
*

 U937 cells were pretreated with inhibitors for 2 h before exposure to TNF or UV light. After 1 h of incubation, cells were pelleted, washed twice in PBS, and lysed to measure protease activity on the DEVD–pNa substrate. The percent morphologically apoptotic cells and percent DNA fragmentation was determined after 1.5 h incubation. ND, not determined.